Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ofer Hi-Tech, now primarily operating as XT Hi-Tech, is a leading Israeli venture capital firm specializing in early-stage and growth-stage investments within the life sciences, medical device, and high-technology sectors. As the technology investment arm of the XT Group, the firm leverages significant financial resources and deep industry expertise to support innovative startups from inception through commercialization. Their healthcare portfolio includes a diverse range of companies focusing on biopharmaceuticals, digital health, and advanced medical instrumentation. Ofer Hi-Tech is recognized for its hands-on approach, providing strategic guidance and global networking opportunities to its portfolio companies. The firm has a strong track record of successful exits through both acquisitions and initial public offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ofer Hi-Tech Investments.